Metastasis of Lobular Breast Carcinoma to Cervix: A Case Report

Authors

  • Rajnish Nagarkar Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
  • Sirshendu Roy Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
  • Tejashree Deshpande Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
  • Shrikant Suryavanshi Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
  • Swapnali Mandlik Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India

Keywords:

Lobular carcinoma, genital mets, cervix

Abstract

In India breast cancer is a very common malignancy. About 1 in 22 Indian women will develop invasive breast cancer during their lifetime. The incidence in US is 1 in 8 women. Increased incidence can be attributed to lifestyle. Among the two major subtypes of carcinoma breast lobular cancer is rare. Common sites of metastasis are lung, liver, bone, brain. Metastasis of lobular carcinoma to cervix is a very uncommon occurrence with a frequency of 0.8–1.7%. Common histological type of breast cancer is ductal carcinoma and common sites of metastasis are lung, liver, bone and brain. Invasive ductal carcinoma does not as frequently metastasis to gynaecologic organs as invasive lobular carcinoma. In genital tract, ovary happens to be the most commonly affected organ by carcinoma breast metastasis. Metastasis to uterine cervix in a patient of breast carcinoma is a very rare occurrence. The most common type metastasising to cervix is lobular carcinoma. The most common presenting symptom is abnormal per vaginal bleeding, abdominal pain. These symptoms mimic a primary gynaecologic neoplasm. We herein report the first case in our set up of isolated uterine cervical metastasis in a postmenopausal patient who had invasive lobular carcinoma of breast and was on hormonal treatment. A case report of 47 year old patient 10 years post mastectomy presented with multiple bony, cervical metastases. Patient responded well to hormonal therapy i.e. everolimus plus exemestane. Patient is on regular follow up with complete tumour response. This case report insists on more thorough gynaecologic examination in a patient of carcinoma breast.

Keywords: Lobular carcinoma, genital metastasis, cervix, Breast Carcinoma, adenocarcinoma

Cite this Article

Rajnish Nagarkar, Sirshendu Roy, Tejashree Deshpande et al. Metastasis of Lobular Breast Carcinoma to Cervix: A Case Report. Reseach & Reviews: Journal of Oncology & Hematology. 2016; 5(2): 11–14p.


 

Author Biographies

  • Sirshendu Roy, Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
    Department of Surgical Oncology
  • Tejashree Deshpande, Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
    Department of Surgical Oncology
  • Shrikant Suryavanshi, Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
    Department of Surgical Oncology
  • Swapnali Mandlik, Department of Surgical Oncology, Manavata Clinical Research Institute, Curie Manavata Cancer Centre, Maharashtra, Nashik, India
    Department of Surgical Oncology

Downloads

Published

2016-08-24

Issue

Vol. 5 No. 2 (2016)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.